Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absent cone function and stable ophthalmic features in a non-syndromic woman with pathogenic variants in <i>CEP290</i>.

Ophthalmic genetics·2026
Same author

Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho<sup>∆I255</sup> mice.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

PARP Activity Is Essential for Retinal Photoreceptor Survival in the Human Homologous Rho<sup>I255del</sup> Mouse Model for Autosomal Dominant Retinitis Pigmentosa.

Journal of neurochemistry·2025
Same author

Quantitative Proteomics Identifies Potential Molecular Adaptations in Mouse Models of Congenital Stationary Night Blindness Type 2.

Molecular & cellular proteomics : MCP·2025
Same author

APOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in Rodents.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Genetic Loss of RORα Impairs Visual Function With Rod Bipolar Cell Degeneration In Mice.

Investigative ophthalmology & visual science·2025

Related Experiment Video

Updated: Jul 5, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Retinal degenerative and hypoxic ischemic disease.

Anne B Fulton1, James D Akula, Julie A Mocko

  • 1Department of Ophthalmology, Children's Hospital Boston and Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA. Anne.Fulton@childrens.harvard.edu

Documenta Ophthalmologica. Advances in Ophthalmology
|May 17, 2008
PubMed
Summary

Protecting immature photoreceptors and targeting neural-vascular interactions may prevent or treat retinopathy of prematurity (ROP). Early intervention in ROP shows promise for improving visual outcomes and reducing vascular abnormalities.

More Related Videos

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Experiment Videos

Last Updated: Jul 5, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Area of Science:

  • Ophthalmology
  • Developmental Biology
  • Pharmacology

Background:

  • Retinal diseases impact vasculature and neural retina, affecting photoreceptor and postreceptor cells.
  • Retinopathy of prematurity (ROP) is characterized by abnormal retinal vasculature and neural structure/function deficits.
  • Early and persistent effects on neural retina are key features of ROP.

Purpose of the Study:

  • To investigate longitudinal electroretinographic (ERG) and vascular changes in rodent models of human ROP.
  • To identify potential pharmaceutical intervention targets for ROP based on observed neural and vascular development.
  • To explore therapeutic strategies for preventing ROP and improving visual outcomes.

Main Methods:

  • Longitudinal studies using induced retinopathies in rats to model human ROP.
  • Assessment of electroretinographic (ERG) parameters to evaluate neural function.
  • Monitoring of retinal vascular features in response to induced retinopathy.

Main Results:

  • Photoreceptor status at an early age correlates with later vascular outcomes in ROP models.
  • Immature photoreceptors represent a potential target for ROP prevention.
  • Cooperative development of neural and vascular retinal networks suggests a second intervention target.

Conclusions:

  • Pharmaceutical interventions targeting immature photoreceptors may prevent ROP.
  • Interventions focusing on the neural-vascular network interplay can improve visual outcomes and reduce vascular abnormalities.
  • Understanding ROP's dual impact on neural and vascular components is crucial for therapeutic development.